Athersys
ATHX
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Net assets
Net assets on the balance sheet as of September 2023 : -$36.4 M
According to Athersys's latest financial reports the company has -$36.4 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Athersys - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-23.86 M | -245.71% |
| 2021-12-31 | $16.36 M | -47.81% |
| 2020-12-31 | $31.36 M | 34.77% |
| 2019-12-31 | $23.27 M | -46.03% |
| 2018-12-31 | $43.11 M | 84.45% |
| 2017-12-31 | $23.37 M | 109.07% |
| 2016-12-31 | $11.18 M | -43.31% |
| 2015-12-31 | $19.72 M | -5.6% |
| 2014-12-31 | $20.89 M | 5.42% |
| 2013-12-31 | $19.82 M | -2.1% |
| 2012-12-31 | $20.24 M | 177.43% |
| 2011-12-31 | $7.29 M | -18.96% |
| 2010-12-31 | $9 M | -52.5% |
| 2009-12-31 | $18.95 M | -39.94% |
| 2008-12-31 | $31.56 M | -33.73% |
| 2007-12-31 | $47.63 M | -9321235.03% |
| 2006-12-31 | $-0.01 M | -151.1% |
| 2005-12-31 | $0 M | 0% |
| 2004-12-31 | $0 M | -99.99% |
| 2003-12-31 | $14.95 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -189,065.52% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | -245,430.40% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | -17,223.23% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | -225,964.54% | 🇫🇷 France |
 Merck MRK | $37.63 B | -103,507.06% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $29.48 B | -81,113.88% | 🇺🇸 USA |
 Moderna
MRNA | $13.85 B | -38,165.67% | 🇺🇸 USA |